Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14570472 | 0.80 | TAAR1 (0.65) | TAAR1 | |
| SCHEMBL5309200 | 0.80 | TAAR1 (0.65) | TAAR1 | |
| Hydrochloric Acid SCHEMBL5309198 | 0.78 | TAAR1 (0.63) | TAAR1 | |
| Hydrochloric Acid SCHEMBL5309205 | 0.78 | TAAR1 (0.63) | TAAR1 | |
| SCHEMBL21455228 | 0.77 | DPP4 (0.43) | DPP4CYP3A4ALDH1A1KDM4EMEN1 | |
| SCHEMBL31063034 | 0.77 | ALDH1A1 (0.35) | CYP3A4TAAR1ALDH1A1MEN1KMT2A | |
| SCHEMBL8282635 | 0.77 | CYP3A4 (0.51) | DPP4CYP3A4TAAR1ALDH1A1KDM4E | |
| SCHEMBL2124718 | 0.76 | DPP4 (0.46) | DPP4ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL31456004 | 0.76 | HMGCR (0.49) | DPP4CYP3A4TAAR1ALDH1A1KDM4E | |
| SCHEMBL11810881 | 0.75 | KMT2A (0.43) | DPP4KMT2AGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665339-A1 | INHIBITING ALPHA V BETA 8 INTEGRIN | Morphic Therapeutic, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024173570-A1 | INHIBITING αvβ8 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2024-08-22 | — | — | WO | disclosed |